Celgene Patient Support® can assist patients with information about accessing their prescribed Celgene medications
Our Specialists are committed to helping patients get their prescribed Celgene medications, no matter what their insurance situation.
Physician-Administered Products
Financial assistance
Financial assistance options may be available for each insurance situation.
No matter what type of insurance your patients have, Celgene Patient Support® is committed to helping patients get REBLOZYL®.
Celgene Commercial Co-pay Program*
For eligible patients who have commercial or private insurance
(including healthcare exchanges)
- Provides assistance to help patients meet co-pay/co-insurance costs
$0 Co-pay for Eligible Patients (subject to annual benefit limits)
Eligibility criteria for patients include*
- Commercial or private insurance that does not cover the full cost of the prescribed Celgene medication
- Residence in the United States or US territory
- Patients with government healthcare insurance (for example, Medicare, Medicaid, Medigap, TriCare, CHAMPVA) are not eligible
Independent Third-Party Organizations†
For patients who are unable to afford their medication
(including patients with Medicare, Medicaid, or other government-sponsored insurance)
Funds may be available for:
- Deductibles
- Co-payments/co-insurance
- Insurance premiums
Transportation assistance
- Independent third-party organizations may be able to help with travel costs to and from your doctor’s office, including gas, tolls, parking, and taxi, bus, or train fare
Eligibility requirements
- Financial and medical eligibility requirements vary by organization
Celgene Patient Assistance Program (PAP)‡
For qualified patients who are uninsured or underinsured
- REBLOZYL® may be available at no cost to patients who meet insurance and financial criteria
- We can also help educate patients about insurance coverage or other programs for which they may qualify
Eligibility requirements
- Patients must meet specified financial and eligibility requirements to qualify for assistance
Financial assistance
Financial assistance options may be available for each insurance situation.
No matter what type of insurance your patients have, Celgene Patient Support® is committed to helping patients get ABRAXANE®.
Celgene Commercial Co-pay Program*
For eligible patients who have commercial or private insurance
(including healthcare exchanges)
- Provides assistance to help patients meet co-pay/co-insurance costs
$0 Co-pay for Eligible Patients (subject to annual benefit limits)
Eligibility criteria for patients include*
- Commercial or private insurance that does not cover the full cost of the prescribed Celgene medication
- Residence in the United States or US territory
- Patients with government healthcare insurance (for example, Medicare, Medicaid, Medigap, TriCare, CHAMPVA) are not eligible
Independent Third-Party Organizations†
For patients who are unable to afford their medication
(including patients with Medicare, Medicaid, or other government-sponsored insurance)
Funds may be available for:
- Deductibles
- Co-payments/co-insurance
- Insurance premiums
Transportation assistance
- Independent third-party organizations may be able to help with travel costs to and from your doctor’s office, including gas, tolls, parking, and taxi, bus, or train fare
Eligibility requirements
- Financial and medical eligibility requirements vary by organization
Celgene Patient Assistance Program (PAP)‡
For qualified patients who are uninsured or underinsured
- ABRAXANE may be available at no cost to patients who meet insurance and financial criteria
- We can also help educate patients about insurance coverage or other programs for which they may qualify
Eligibility requirements
- Patients must meet specified financial and eligibility requirements to qualify for assistance
Self-Administered Products
Fast Track for First Prescription®
The unique quick-start program from Celgene Patient Support®— designed to accelerate patient access to their first prescription for REVLIMID*
Learn more about the Fast Track for First Prescription®
*Prescription must be for an approved indication for REVLIMID.
Financial assistance
Financial assistance options may be available for each insurance situation.
No matter what type of insurance your patients have, Celgene Patient Support® is committed to helping patients get REVLIMID.
Celgene Commercial Co-pay Program*
For eligible patients who have commercial or private insurance
(including healthcare exchanges)
- Provides assistance to help patients meet co-pay/co-insurance costs
$25 Co-pay for Eligible Patients (subject to annual benefit limits)
Eligibility criteria for patients include*
- Commercial or private insurance that does not cover the full cost of the prescribed Celgene medication
- Residence in the United States or US territory
- Patients with government healthcare insurance (for example, Medicare, Medicaid, Medigap, TriCare, CHAMPVA) are not eligible
Independent Third-Party Organizations†
For patients who are unable to afford their medication
(including patients with Medicare, Medicaid, or other government-sponsored insurance)
Funds may be available for:
- Deductibles
- Co-payments/co-insurance
- Insurance premiums
Transportation assistance
- Independent third-party organizations may be able to help with travel costs to and from your doctor’s office, including gas, tolls, parking, and taxi, bus, or train fare
Eligibility requirements
- Financial and medical eligibility requirements vary by organization
Celgene Patient Assistance Program (PAP)‡
For qualified patients who are uninsured or underinsured
- REVLIMID may be available at no cost to patients who meet insurance and financial criteria
- We can also help educate patients about insurance coverage or other programs for which they may qualify
Eligibility requirements
- Patients must meet specified financial and eligibility requirements to qualify for assistance
Patient Financial Brochures
Fast Track for First Prescription®
The unique quick-start program from Celgene Patient Support®— designed to accelerate patient access to their first prescription for POMALYST*
Learn more about the Fast Track for First Prescription®
*Prescription must be for an approved indication for POMALYST.
Financial assistance
Financial assistance options may be available for each insurance situation.
No matter what type of insurance your patients have, Celgene Patient Support® is committed to helping patients get POMALYST.
Celgene Commercial Co-pay Program*
For eligible patients who have commercial or private insurance
(including healthcare exchanges)
- Provides assistance to help patients meet co-pay/co-insurance costs
$25 Co-pay for Eligible Patients (subject to annual benefit limits)
Eligibility criteria for patients include*
- Commercial or private insurance that does not cover the full cost of the prescribed Celgene medication
- Residence in the United States or US territory
- Patients with government healthcare insurance (for example, Medicare, Medicaid, Medigap, TriCare, CHAMPVA) are not eligible
Independent Third-Party Organizations†
For patients who are unable to afford their medication
(including patients with Medicare, Medicaid, or other government-sponsored insurance)
Funds may be available for:
- Deductibles
- Co-payments/co-insurance
- Insurance premiums
Transportation assistance
- Independent third-party organizations may be able to help with travel costs to and from your doctor’s office, including gas, tolls, parking, and taxi, bus, or train fare
Eligibility requirements
- Financial and medical eligibility requirements vary by organization
Celgene Patient Assistance Program (PAP)‡
For qualified patients who are uninsured or underinsured
- POMALYST may be available at no cost to patients who meet insurance and financial criteria
- We can also help educate patients about insurance coverage or other programs for which they may qualify
Eligibility requirements
- Patients must meet specified financial and eligibility requirements to qualify for assistance
Patient Financial Brochures
Financial assistance
Financial assistance options may be available for each insurance situation.
No matter what type of insurance your patients have, Celgene Patient Support® is committed to helping patients get INREBIC®.
Celgene Commercial Co-pay Program*
For eligible patients who have commercial or private insurance
(including healthcare exchanges)
- Provides assistance to help patients meet co-pay/co-insurance costs
$25 Co-pay for Eligible Patients (subject to annual benefit limits)
Eligibility criteria for patients include*
- Commercial or private insurance that does not cover the full cost of the prescribed Celgene medication
- Residence in the United States or US territory
- Patients with government healthcare insurance (for example, Medicare, Medicaid, Medigap, TriCare, CHAMPVA) are not eligible
Independent Third-Party Organizations†
For patients who are unable to afford their medication
(including patients with Medicare, Medicaid, or other government-sponsored insurance)
Funds may be available for:
- Deductibles
- Co-payments/co-insurance
- Insurance premiums
Transportation assistance
- Independent third-party organizations may be able to help with travel costs to and from your doctor’s office, including gas, tolls, parking, and taxi, bus, or train fare
Eligibility requirements
- Financial and medical eligibility requirements vary by organization
Celgene Patient Assistance Program (PAP)‡
For qualified patients who are uninsured or underinsured
- INREBIC® may be available at no cost to patients who meet insurance and financial criteria
- We can also help educate patients about insurance coverage or other programs for which they may qualify
Eligibility requirements
- Patients must meet specified financial and eligibility requirements to qualify for assistance
Financial assistance
Financial assistance options may be available for each insurance situation.
No matter what type of insurance your patients have, Celgene Patient Support® is committed to helping patients get IDHIFA®.
Celgene Commercial Co-pay Program*
For eligible patients who have commercial or private insurance
(including healthcare exchanges)
- Provides assistance to help patients meet co-pay/co-insurance costs
$25 Co-pay for Eligible Patients (subject to annual benefit limits)
Eligibility criteria for patients include*
- Commercial or private insurance that does not cover the full cost of the prescribed Celgene medication
- Residence in the United States or US territory
- Patients with government healthcare insurance (for example, Medicare, Medicaid, Medigap, TriCare, CHAMPVA) are not eligible
Independent Third-Party Organizations†
For patients who are unable to afford their medication
(including patients with Medicare, Medicaid, or other government-sponsored insurance)
Funds may be available for:
- Deductibles
- Co-payments/co-insurance
- Insurance premiums
Transportation assistance
- Independent third-party organizations may be able to help with travel costs to and from your doctor’s office, including gas, tolls, parking, and taxi, bus, or train fare
Eligibility requirements
- Financial and medical eligibility requirements vary by organization
Celgene Patient Assistance Program (PAP)‡
For qualified patients who are uninsured or underinsured
- IDHIFA may be available at no cost to patients who meet insurance and financial criteria
- We can also help educate patients about insurance coverage or other programs for which they may qualify
Eligibility requirements
- Patients must meet specified financial and eligibility requirements to qualify for assistance
Celgene Healthcare Professional Support Brochure
A complete program overview you can print and keep.
If you prefer, you can download and print the Celgene Healthcare Professional Support brochure for quick reference. The brochure contains all the information you need about patient financial assistance and our insurance-related support for Celgene medications.
REVLIMID® (lenalidomide) and POMALYST® (pomalidomide) are only available through restricted distribution programs.
Please see full Prescribing Information, including Boxed WARNINGS, for REVLIMID®, POMALYST®, IDHIFA® (enasidenib), INREBIC® (fedratinib), and ABRAXANE® for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) (albumin-bound). Please see full prescribing information for REBLOZYL® (luspatercept-aamt).
